The nuclear factor kB (NFkB) transcription factor plays critical roles in inflammation and immunity. The dysregulation of NFkB is associated with inflammatory and autoimmune diseases and cancer. NFkB activation is negatively regulated by the ubiquitin-dependent proteasomal degradation pathway. In the present review, we discuss recent advances in our understanding of how ubiquitin ligases regulate the NFkB degradation pathway. Keywords: NFkB; ubiquitination; degradation; pathway Nuclear factor kB (NFkB) was identified approximately 20 years ago by Dr David Baltimore as a transcription factor that binds to the intronic enhancer of the kappa light chain gene (the kB site) in B cells. 1 The NFkB family is composed of several members including p50, p52, p65/RelA, c-Rel and RelB and plays a central role in cell growth, inflammation, immunity and apoptosis. NFkB activation is dependent on the stability of the inhibitor IkBa. IkBa stabilizes the NFkB complex so that after its degradation the remaining subunits translocate from the cytoplasm to the nucleus. 2 The phosphorylation of IkBa is catalyzed by IkB kinase (IKK), a complex composed of three subunits: IKKa/IKK1, IKKb/IKK2, and IKKc/NEMO. IKK1 and IKK2 are the catalytic subunits, whereas IKKc serves as a non-enzymatic regulator. [3][4][5] The IKKs/NFkB pathway is activated by extracellular stimuli such as cytokines, ultraviolet irradiation, free radicals, bacterial or viral antigens and oxidized low density lipoprotein. 3,4 In the absence of persistent upstream stimuli, NFkB transcriptional activity is terminated by the NFkB/IkBa negative feedback loop. 4 The activation of NFkB in immune or stromal cells causes a pro-inflammatory response, and persistent tissue inflammation has been linked to inflammation-associated cancer. 6 NFkB activation is negatively regulated by ubiquitin-dependent proteasomal degradation. 7-9 The ubiquitin-proteasome system comprises a ubiquitin-activating enzyme (E1), a ubiquitinconjugating enzyme (E2) and a ubiquitin ligase (E3). Ubiquitin E3 ligases play a critical role in substrate recognition and polyubiquitination by recruiting E2 ubiquitin-conjugating enzymes to specific substrates. 10 SOCS-1 (suppressor of cytokine signaling) is one of the components of the EC 2 S (Elongin BC-CUL2-SOCS-box protein) ubiquitin ligase complex that mediates JAK2 (Janus kinase 2) ubiquitination and degradation. 11,12 Similar to JAK2, NFkB/p65 is also a substrate of the EC 2 S ubiquitin ligase complex in both mice and cancer cells. 13 Pin1 increases NFkB/p65 stability and transactivation, while the loss of Pin1 leads to SOCS-1-mediated p65 ubiquitination and degradation. 13 This offers a new mechanism for NFkBmediated pathogenesis.NFkB is also activated by viral infections. In immunodeficiency virus-1-infected CD4 1 lymphocytes, NFkB activation is terminated by COMMD1 (MURR1), resulting in the inhibition of immunodeficiency virus-1 growth in unstimulated or cytokine-stimulated CD4 1 T cells. 14 This study demonstrated that COMMD1 decreases NFkB transcriptio...